{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T16:06:30Z","timestamp":1732032390324},"reference-count":36,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.vaccine.2007.02.085","type":"journal-article","created":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T16:40:15Z","timestamp":1178210415000},"page":"5725-5734","source":"Crossref","is-referenced-by-count":10,"title":["Eczema vaccinatum as an adverse event following exposure to vaccinia virus: Case definition & guidelines of data collection, analysis, and presentation of immunization safety data"],"prefix":"10.1016","volume":"25","author":[{"given":"Patricia","family":"Nell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin S.","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip S.","family":"LaRussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Michael","family":"Marcy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent A.","family":"Fulginiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Trolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.02.085_bib1","unstructured":"World Health Organization. Declaration of global eradication of smallpox. Wkly Epidemiol Rec 1980;55:148."},{"key":"10.1016\/j.vaccine.2007.02.085_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3201\/eid0504.990402","volume":"5","author":"Henderson","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.02.085_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3201\/eid0504.990402","article-title":"Bioterrorism; how prepared are we?","volume":"5","author":"Shalala","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.02.085_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3201\/eid0504.990413","article-title":"Vaccines in civilian defense against bioterrorism","volume":"5","author":"Russel","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.02.085_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa013431","article-title":"Dose-related Effects of smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.02.085_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa020534","article-title":"Clinical responses to undiluted and diluted smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2007.02.085_bib7","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","article-title":"Response to smallpox vaccine in persons immunized in the distant past","volume":"289","author":"Frey","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.02.085_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2007.02.063","article-title":"The development of standardized case definitions and guidelines for adverse events following immunization","author":"Kohl","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.085_bib9","unstructured":"Centers for Disease Control and Prevention. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR 2006;55(RR-1):1\u201316."},{"key":"10.1016\/j.vaccine.2007.02.085_bib10","unstructured":"CDC. Vaccinia (Smallpox) Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR 2001; 50(RR10);1\u201325. Report available on the world wide web: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5010a1.htm (last accessed February 9, 2006)."},{"key":"10.1016\/j.vaccine.2007.02.085_bib11","unstructured":"CDC. Smallpox Vaccination and adverse reactions. Guidance for Clinicians. MMWR 2003;52(RR-4):1\u201328. Available on the world wide web: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5204a1.htm (last accessed February 9, 2006)."},{"key":"10.1016\/j.vaccine.2007.02.085_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: A review. Part II. Adverse events","volume":"37","author":"Fulginity","year":"2003","journal-title":"CID"},{"key":"10.1016\/j.vaccine.2007.02.085_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaci.2003.07.002","article-title":"Editorial: risks of smallpox vaccination: 200 years after Jenner","volume":"112","author":"Plaut","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2007.02.085_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2458-3-26","article-title":"Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963\u20131968","volume":"3","author":"Aragon","year":"2003","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2007.02.085_bib15","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/bmj.2.5414.906","article-title":"Eczema vaccinatum","volume":"2","author":"Copeman","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2007.02.085_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2133.1994.tb08530.x","article-title":"The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis","volume":"131","author":"Williams","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.vaccine.2007.02.085_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2133.1994.tb08532.x","article-title":"The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation","volume":"131","author":"Williams","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.vaccine.2007.02.085_bib18","series-title":"Atopic dermatitis. Middleton's allergy principles and practice, ED 6","author":"Boguniewicz","year":"2003"},{"key":"10.1016\/j.vaccine.2007.02.085_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.1973.tb02997.x","article-title":"Eczema vaccinatum in a family with Darier's disease","volume":"89","author":"Salo","year":"1973","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.vaccine.2007.02.085_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00128071-200304020-00003","article-title":"Darier's disease: epidemiology, pathophysiology, and management","volume":"4","author":"Cooper","year":"2003","journal-title":"Am J Clin Dermatology"},{"key":"10.1016\/j.vaccine.2007.02.085_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2230.1994.tb01165.x","article-title":"Darier's disease\u2014the clinical features and pathogenesis","volume":"19","author":"Burge","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.vaccine.2007.02.085_bib22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaci.2003.07.001","article-title":"Viral infections in atopic dermatitis: pathogenic aspects and clinical management","volume":"112","author":"Wollenberg","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2007.02.085_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mai.2002.128052","volume":"110","author":"Engler","year":"2002","journal-title":"J Allergy Clin Immun"},{"key":"10.1016\/j.vaccine.2007.02.085_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-139-1-200307010-00006","article-title":"Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination","volume":"139","author":"Naleway","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2007.02.085_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2133.1994.tb08531.x","article-title":"The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer vaccination of clinical diagnosis and signs of atopic dermatitis","volume":"131","author":"Williams","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.vaccine.2007.02.085_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8561(03)00066-3","article-title":"Epidemiolgy of atopic dermatitis","volume":"22","author":"Larsen","year":"2002","journal-title":"Immunol Allerg Clin N Am"},{"key":"10.1016\/j.vaccine.2007.02.085_bib27","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.288.15.1901","article-title":"Contact vaccinia\u2014transmission of vaccinia from smallpox vaccination","volume":"288","author":"Neff","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.02.085_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1542\/peds.26.2.176","article-title":"Studies on smallpox and complications of smallpox vaccination","volume":"26","author":"Kempe","year":"1960","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2007.02.085_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5694\/j.1326-5377.1977.tb114544.x","article-title":"Adverse reactions after smallpox vaccination","volume":"2","author":"Feery","year":"1977","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2007.02.085_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/milmed\/165.4.287","article-title":"Adverse reactions to smallpox vaccine: the Israel Defense Force experience, 1991 to 1996. A comparison with previous surveys","volume":"165","author":"Haim","year":"2000","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2007.02.085_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(66)90006-7","article-title":"Treatment of eczema vaccinatum with N-methylisatin beta-thiosemicarbazone","volume":"1","author":"Adels","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.02.085_bib32","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for Clinical Safety assessment (E2a-e). Available on the world wide web: http:\/\/www.ich.org\/ (last accessed February 9, 2006)."},{"key":"10.1016\/j.vaccine.2007.02.085_bib33","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). Reporting form for International Reporting of Adverse Drug Reactions. Available on the world wide web: http:\/\/www.cioms.ch\/frame_what_is_cioms.htm (last accessed February 9, 2006)."},{"key":"10.1016\/j.vaccine.2007.02.085_bib34","doi-asserted-by":"crossref","unstructured":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987\u201391. Available on the world wide web: http:\/\/www.consort-statement.org\/Statement\/revisedstatement.htm (last accessed February 9, 2006).","DOI":"10.1001\/jama.285.15.1987"},{"key":"10.1016\/j.vaccine.2007.02.085_bib35","unstructured":"Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193):1896\u2013900. Available on the world wide web: http:\/\/www.consort-statement.org\/Initiatives\/complements.htm (last accessed February 9, 2006)."},{"key":"10.1016\/j.vaccine.2007.02.085_bib36","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008\u201312. Available on the world wide web: http:\/\/www.consort-statement.org\/Initiatives\/complements.htm (last accessed February 9, 2006).","DOI":"10.1001\/jama.283.15.2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T02:20:47Z","timestamp":1707877247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07002691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":36,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0264410X07002691"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.02.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}